Physical activity in South Asian men with prostate cancer Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Participants may enter the study if ALL of the following apply: 1. Adult men (=18 years) 2. Previously diagnosed or newly diagnosed with localised or locally advanced prostate cancer 3. South Asian heritage 4. Capacity to give informed consent
Exclusion criteria
Exclusion criteria: Participants may not enter the study if ANY of the following apply: 1. Inability to give informed consent 2. Identified as unsuitable to participate by their clinician, e.g. due to co-morbidities, treatment being received, or any other contraindications to exercise 3. Use of a mobility aid other than a walking stick, which would prevent them from carrying out the brisk walking intervention 4. Inability to give informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The feasibility of recruiting men of South Asian heritage with prostate cancer to a physical activity intervention and adherence to the intervention will be measured using questionnaires and logs to record their step counts for 1 week when they join the study, and after 6 weeks, 3 months and four months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Implementation fidelity: The extent to which participants complete the brisk walking intervention as prescribed (30 minutes/day, 5 days/week for 3 months). 2. Retention rate: Proportion of participants who remain in the study for the full duration of the intervention. 3. Feasibility of physical activity data collection: Completeness and usability of step count data recorded via pedometers/accelerometers and participant logs at baseline, 6 weeks, 3 months, and 4 months. 4. Feasibility of clinical and self-reported data collection: Completeness of participant-reported outcomes (e.g. symptoms, quality of life) and clinical data (e.g. PSA levels) from questionnaires and medical records. 5. Acceptability of the intervention: Participant and clinician feedback on the walking programme, gathered through focus groups and interviews. 6. Acceptability of trial procedures: Participant feedback on study processes, including reasons for declining participation. 7. Informing future trial design: Use of physical activity and outcome data to guide the development of a larger clinical trial. | — |
Countries
England, United Kingdom
Contacts
;